1.
Blauvelt A, Thaci D, Papp K, Ho V, Ghoreschi K, Kim BS, Miller M, Shen Y-K, You Y, Yu J, Yang Y-W, Crowley J, Foley P. Guselkumab (GUS) in Psoriasis Patients With a History of Malignancy: 5-Year Safety From VOYAGE (VOY)1&2 . J of Skin [Internet]. 2022Mar.4 [cited 2022Aug.16];6(2):s2. Available from: https://www.jofskin.org/index.php/skin/article/view/1517